Effects of feto-placental markers with plasma exchange in pregnancy. 1994

R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
Department of Medicine, Pennsylvania Hospital, Philadelphia.

To evaluate changes in feto-placental markers with plasma exchange in pregnancy, two patients at varying stages of pregnancy referred to a tertiary care hospital and requiring plasma exchange for intercurrent problems were evaluated. Alpha-fetoprotein, human chorionic gonadotropin, and free estriol were sequentially measured in the patients' plasma and in the fluid removed, thus permitting calculations of permeability rates and clearances. Despite markedly different molecular weights, all three feto-placental markers had similar permeabilities and clearances. While in both patients maternal levels of alpha-fetoprotein and human chorionic gonadotropin decreased rapidly with plasma separation and rebounded rapidly to baseline, free estriol responded differently and did not appear to decrease with therapy. Maternal levels of feto-placental markers only transiently changed with plasma exchange during pregnancy and rapidly returned to baseline with no apparent consequences to the pregnancy.

UI MeSH Term Description Entries
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D004964 Estriol A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol. (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,(16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,16-alpha-Hydroxy-Estradiol,16alpha,17beta-Estriol,16beta-Hydroxy-Estradiol,Epiestriol,Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol,Ovestin,16 alpha Hydroxy Estradiol,16alpha,17beta Estriol,16beta Hydroxy Estradiol
D005260 Female Females
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000509 alpha-Fetoproteins The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life. alpha-Fetoprotein,alpha Fetoprotein,alpha Fetoproteins

Related Publications

R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
May 2012, Wiener medizinische Wochenschrift (1946),
R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
January 1977, Panminerva medica,
R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
July 1965, Lyon medical,
R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
March 1987, Experimental and clinical endocrinology,
R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
December 1987, Akusherstvo i ginekologiia,
R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
October 1968, Revue medicale de Liege,
R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
January 1986, Akusherstvo i ginekologiia,
R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
January 1972, Pathologica,
R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
January 1983, Archives d'anatomie et de cytologie pathologiques,
R E Gerhardt, and J D Koethe, and K A Ntoso, and S Lodge, and S Schlaff, and C J Wolf
August 1979, Akusherstvo i ginekologiia,
Copied contents to your clipboard!